Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion type Assertion NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_head.
- NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion description "[36.6% of the patients with MDS and myelofibrosis developed a transformation into ANLL during the course of the disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_provenance.
- NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion evidence source_evidence_literature NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_provenance.
- NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion SIO_000772 1592101 NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_provenance.
- NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion wasDerivedFrom befree-2016 NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_provenance.
- NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_assertion wasGeneratedBy ECO_0000203 NP496757.RA008gwwdPPRVzQt_97BEVNlywP0132u4fkYL6H0LMpg8130_provenance.